1Pirmohamed M, Breckenridge A, Kitteringham N, et al. Adverse drug reactions[J]. BMJ, 1998, 316(7 140): 1 295.
2Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients-excess length of stay, extra costs, and attributable mortality[J]. JAMA, 1997, 277(4):301.
3Vessal G, Mardani Z, Mollai M. Knowledge, attitude, and perceptions of pharmacists to adverse drug reaction reporting in Iran[J]. Pharm WorldSci, 2009, 31 (2) : 183.
4Green CF, Mottram DR, Rowe PH, et al. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting[J]. Br J Clin Pharmacol, 2001,51 ( 1 ) : 81.
5Eland IA, Belton K J, van Grootheest AC, et al. Attitudinal survey of voluntary reporting of adverse drug reactions[J]. BrJ Clin Pharmacol, 1999,48(4) : 623.
5Stapleton J. Liability for drugs in the U. S. and EU: rhetoric and reality[-J-1. The Review of Litigation, 2007(26) :991.
6Fuda C,Suvorov M.Shared functional attributes between themecA gene product of Staphylococcus sciuri and penicill in binding protein 2a of methicillin resistant staphylococcus aureus[J].Biochemistry,2012,46(27): 8050-8057.
